Market Cap

Shenzhen Kangtai Biological Products Co. Ltd Market Capitalization:

CN¥16.80 Billion

CNY as of July 1, 2024

US$2.31 Billion

business Shenzhen Kangtai Biological Products Co. Ltd Company Profile

Shenzhen Kangtai Biological Products Co. Ltd Main Stock Listing

SZSE: 300601

Market Capitalization History of Shenzhen Kangtai Biological Products Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Shenzhen Kangtai Biological Products Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥28.18 B -26.29%
Jan. 1, 2023 CN¥38.23 B -32.59%
Jan. 1, 2022 CN¥56.71 B -45.86%
Jan. 1, 2021 CN¥104.74 B 47.65%
Jan. 1, 2020 CN¥70.94 B 255.34%
Jan. 1, 2019 CN¥19.96 B -5.12%
Jan. 1, 2018 CN¥21.04 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Shenzhen Kangtai Biological Products Co. Ltd Categories

China languages Healthcare languages Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Stocks & Indices

Shenzhen Kangtai Biological Products Co. Ltd has the following listings and related stock indices.


Stock: SZSE: 300601

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.